The FY26 Alzheimer’s Research Program Transforming Research Award supports robust, non-incremental research aimed at transformative advancements in reducing risk and preventing Alzheimer's disease and related dementias. Projects must focus on understanding risk factors or developing risk reduction solutions. Clinical research is allowed, but clinical trials and animal research are excluded. Preliminary data and community collaboration for human subject research are required. A partnership option supports multiple PIs.
Open to all entity types with no specific restrictions stated. Community collaboration required for research enrolling human subjects. At least one independent investigator required for partnership option.
